The FDA has approved VIZZ, the first aceclidine-based eye drop for presbyopia, offering millions of adults over 45 a fast-acting,| MyElectricSparks MES
LENZ Therapeutics is a pharmaceutical company focused on the commercialization of VIZZ™ (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of presbyopia.| LENZ Therapeutics, Inc.
The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration (FDA) and will be available within three months.| New Atlas